Hims & Hers Health Stock Resumes Climb on Acquisition News

Core Viewpoint - Hims & Hers Health Inc is facing significant challenges, with its stock near 17-month lows despite a recent acquisition of Eucalyptus for $1.15 billion and plans for global expansion [1][2]. Group 1: Stock Performance - Shares of Hims & Hers Health have experienced volatile performance, dropping 90% from a record high of $72.98 on February 19, and currently trading at $15.91 [1][2]. - The stock has only seen two gains in the last 14 trading sessions, indicating a prolonged period of underperformance [2]. Group 2: Market Indicators - The stock's 14-day Relative Strength Index (RSI) is at 10.2, indicating it is deeply in "oversold" territory, suggesting a potential for a short-term bounce [2]. - Short interest in Hims & Hers Health has increased by 14.4% over the past two reporting periods, now representing approximately 37.5% of the stock's available float [3].